Secondary infections in dracunculiasis: bacteria and morbidity.
In the course of a study to determine the nature and type of secondary bacterial infection in dracunculiasis. The most common organisms cultured from lesions were Escherichia coli, Enterobacter and Staphylococcus aureus. E. coli and Enterobacter which were found to carry high morbidity were sensitive to Gentamycin, Claforan and Septrin.
D002439:Cefotaxime / Q000494:pharmacology / Q000627:therapeutic use; D004320:Dracunculiasis / Q000150:complications* / Q000382:microbiology; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D004754:Enterobacter / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000209:etiology*; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D012874:Skin Diseases, Infectious / Q000209:etiology*; D012883:Skin Ulcer / Q000209:etiology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000209:etiology*; D013211:Staphylococcus aureus / Q000302:isolation & purification; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D005839:Gentamicins; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002439:Cefotaxime